Total Funding
15
Total FundingSeed raised
Growth Score
pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
KinoDyn is a cancer drug discovery company.
Lee M Graves: Co-Founder & Executive Officer- Gary Johnson: Co-Founder & Chief Scientific Officer
About the Company
KinoDyn is a cancer drug discovery company that builds proprietary technology using multiplexed inhibitor beads and mass spectroscopy. The technology simultaneously maps and quantifies important cellular enzymes and kinases and determines their kinome-wide response to targeted therapeutics. It also focused on challenging cancers, including
triple-negative breast cancer, pancreatic cancer, drug-resistant leukemias, and glioblastoma.
